News

Anesthesia Workstation Market size to grow by USD 2,552.7 million from 2022 to 2028; The growing number of surgeries to boost the global market growth

by

NEW YORK, June 13, 2023 /PRNewswire/ — As per Facts and Factors study, the global anesthesia workstation market size was worth USD 1,749.5 million in 2021 and is estimated to grow to USD 2,552.7 million by 2028, with a compound annual growth rate (CAGR) of around 6.5% during the forecast period. Report Link with All Related … Read more

Rehabilitation Hospital of Bowie, a 60-bed inpatient rehabilitation hospital, now open in Maryland

by

BIRMINGHAM, Ala. and BOWIE, Md., June 13, 2023 /PRNewswire/ — Encompass Health (NYSE: EHC) announces the opening of Rehabilitation Hospital of Bowie, a 60-bed inpatient rehabilitation hospital located at 17351 Melford Boulevard. The hospital serves patients recovering from debilitating illnesses and injuries including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and … Read more

FDA Roundup: June 13, 2023

by

SILVER SPRING, Md., June 13, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “Accelerating Rare disease Cures (ARC) Program Emerges as a Conduit for Empowering Rare Disease Stakeholders,” by Kerry Jo Lee, M.D., Associate Director for … Read more

CENTEGIX Applauds Texas after Alyssa’s Law Officially Enacted

by

Texas Governor Greg Abbott signs school safety legislation, Alyssa’s Law Tweet this “Today, Texas has proven itself to be a nationwide leader in school safety,” said CENTEGIX CEO Brent Cobb. “Sadly, recent events have proven what many of us know instinctively: in a crisis, rapid emergency response times save lives, and an effective emergency alert … Read more

CHOP Researchers Develop Universal MHC Molecules that Can be Produced Rapidly at Scale

by

–The molecules open the door for development of immunotherapies that are truly universal and work across HLA types, regardless of patient ancestry— PHILADELPHIA, June 13, 2023 /PRNewswire/ — Class I major histocompatibility complex (MHC-I) proteins play an essential role in the immune system of all jawed vertebrates. The MHC-I displays peptide fragments of proteins from … Read more

Heligenics Unveils A First-Of-Its-Kind Precision Prescription Test For Breast Cancer Therapeutics

by

LAS VEGAS, June 13, 2023 /PRNewswire/ — Heligenics, a cutting-edge biotech company, announces a first-of-its-kind precision genetic test to select among drugs to treat breast cancer. There are multiple drugs available to treat breast cancer. Most patients become drug resistant, meaning that the cancer cells aren’t responding to the drug that is usually able to … Read more

Fertility Specialists Network Expands Boca Fertility with Addition of Two Dynamic Doctors

by

BOCA RATON, Fla., June 13, 2023 /PRNewswire/ — Fertility Specialists Network (“FSN”), a leading physician and scientific-centric network of fertility clinics dedicated to providing superior patient care, is proud to announce the addition of two dynamic doctors to its esteemed team at Boca Fertility in Boca Raton, Florida. This expansion further demonstrates FSN’s commitment to … Read more

GORE LANCE UNE ETUDE POUR COMPARER L’ENDOPROTHESE EXPANSIBLE SUR BALLONNET GORE® VIABAHN® VBX AUX STENTS EN MÉTAL NU

by

L’étude clinique VBX FORWARD de Gore vise à comparer la perméabilité primaire de l’endoprothèse VBX à l’endoprothèse en métal nu afin d’évaluer sa supériorité dans le traitement des maladies occlusives iliaques complexes. FLAGSTAFF, Arizona, 13 juin 2023 /PRNewswire/ — W. L. Gore & Associates (Gore) a annoncé aujourd’hui le lancement de l’étude clinique VBX FORWARD de Gore (NCT05811364) visant à comparer … Read more

Biostage to Host Investor Call

by

HOLLISTON, Mass., June 13, 2023 /PRNewswire/ — Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, including cancer, trauma and birth defects initially in the esophagus and the airway, announced today that it will host an investor call on Tuesday, … Read more

Mission Bio’s Tapestri® Platform Demonstrates Highly Robust And Reproducible Data

by

White paper from Labcorp evaluates the performance of the Tapestri® Platform panel suitable for detection of therapeutic resistance mutations in AML at the single-cell level SOUTH SAN FRANCISCO, Calif., June 13, 2023 /PRNewswire/ — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced today successful results of validation studies of the Tapestri® Platform. Data … Read more